Transarterial Radioembolization Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium

Authors

  • Kabalane Yammine Radiology Department, Clémenceau Medical Center, Beirut, Lebanon Author
  • Sarah Khalife Radiology Department, American University of Beirut, Beirut, Lebanon Author
  • Jihad Dahe Radiology Department, Clémenceau Medical Center, Beirut, Lebanon Author
  • Feras Chehade Nuclear Medicine Unit Clémenceau Medical Center, Beirut, Lebanon Author

DOI:

https://doi.org/10.47363/JONRR/2021(2)139

Keywords:

HCC, Transarterial-Radioembolization, TARE, 99m Tc-MAA-imaging, Yttrium-90-microspheres

Abstract

Tumor thrombus infiltration of hepatocellular carcinoma (HCC) into the inferior vena cava and right atrium is rare and is associated with a poor prognosis due to the critical location of the tumor and the limited efficiency of the available treatment strategies. In this study, we report the case of a patient with advanced HCC and tumor thrombus in the inferior vena cava and right atrium who demonstrated complete response with mass retraction upon Yttrium-90 trans-arterial radioembolization (90Y- TARE) therapy. Throughout the 16 months follow-ups after the radioembolization, the patient was free of any complications, revealing no occurrence of radiation-induced pneumonitis or tumor recurrence.

Author Biographies

  • Kabalane Yammine, Radiology Department, Clémenceau Medical Center, Beirut, Lebanon

    Radiology Department, Clémenceau Medical Center, Beirut, Lebanon 

  • Sarah Khalife, Radiology Department, American University of Beirut, Beirut, Lebanon

    Radiology Department, American University of Beirut, Beirut, Lebanon 

  • Jihad Dahe, Radiology Department, Clémenceau Medical Center, Beirut, Lebanon

    Radiology Department, Clémenceau Medical Center, Beirut, Lebanon

  • Feras Chehade, Nuclear Medicine Unit Clémenceau Medical Center, Beirut, Lebanon

    Nuclear Medicine Unit Clémenceau Medical Center, Beirut, Lebanon 

Downloads

Published

2021-06-23

Issue

Vol. 2 No. 3 (2021): Volume 2 Issue 3

Section

Articles